These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36798965)

  • 1. Understanding medical corruption in China: a mixed-methods study.
    Fu H; Lai Y; Li Y; Zhu Y; Yip W
    Health Policy Plan; 2023 Apr; 38(4):496-508. PubMed ID: 36798965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corruption in Anglophone West Africa health systems: a systematic review of its different variants and the factors that sustain them.
    Onwujekwe O; Agwu P; Orjiakor C; McKee M; Hutchinson E; Mbachu C; Odii A; Ogbozor P; Obi U; Ichoku H; Balabanova D
    Health Policy Plan; 2019 Sep; 34(7):529-543. PubMed ID: 31377775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 4. Moving towards a better path? A mixed-method examination of China's reforms to remedy medical corruption from pharmaceutical firms.
    Shi J; Liu R; Jiang H; Wang C; Xiao Y; Liu N; Wang Z; Shi L
    BMJ Open; 2018 Feb; 8(2):e018513. PubMed ID: 29439069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting anti-corruption, transparency and accountability in the recruitment and promotion of health workers to safeguard health outcomes.
    Kirya MT
    Glob Health Action; 2020; 13(sup1):1701326. PubMed ID: 32194012
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia.
    Naher N; Hoque R; Hassan MS; Balabanova D; Adams AM; Ahmed SM
    BMC Public Health; 2020 Jun; 20(1):880. PubMed ID: 32513131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does health insurance coverage reduce informal payments? Evidence from the "red envelopes" in China.
    Liu N; Bao G; He AJ
    BMC Health Serv Res; 2020 Feb; 20(1):95. PubMed ID: 32028953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Students' Perceptions of University Corruption in a Spanish Public University: A Path Analysis.
    Julián M; Bonavia T
    Front Psychol; 2022; 13():842345. PubMed ID: 35519633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 11. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corruption and health care system].
    Marasović Šušnjara I
    Acta Med Croatica; 2014 Jun; 68(3):243-6. PubMed ID: 26016214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sustainable development goals as a framework to combat health-sector corruption.
    Mackey TK; Vian T; Kohler J
    Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 15. We Need to Talk About Corruption in Health Systems.
    Hutchinson E; Balabanova D; McKee M
    Int J Health Policy Manag; 2019 Apr; 8(4):191-194. PubMed ID: 31050963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untangling the corruption maze: exploring the complexity of corruption in the health sector.
    Sommersguter-Reichmann M; Reichmann G
    Health Econ Rev; 2024 Jul; 14(1):50. PubMed ID: 38995456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corruption and informal sector households' participation in health insurance in Sierra Leone.
    Jofre-Bonet M; Kamara J; Mesnard A
    PLoS One; 2023; 18(4):e0281724. PubMed ID: 37053264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Youths' views on corruption control in China: politics and social censure.
    Jiang G; Lo TW; Li C
    Int J Offender Ther Comp Criminol; 2013 Dec; 57(12):1498-521. PubMed ID: 22965270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corruption and use of antibiotics in regions of Europe.
    Rönnerstrand B; Lapuente V
    Health Policy; 2017 Mar; 121(3):250-256. PubMed ID: 28094050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring corruption in the South African health sector.
    Rispel LC; de Jager P; Fonn S
    Health Policy Plan; 2016 Mar; 31(2):239-49. PubMed ID: 26104821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.